BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020;e13334. [PMID: 32449235 DOI: 10.1111/tid.13334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Fernández-Ruiz M, Aguado JM. Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients. Curr Transplant Rep 2020;:1-11. [PMID: 33110739 DOI: 10.1007/s40472-020-00306-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kotsimbos T, Humbert M. Pandemic treatments on trial: the bigger picture. N of many thinking in an N of one scenario. Eur Respir J 2020;56:2002281. [PMID: 32747396 DOI: 10.1183/13993003.02281-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Granata S, Carratù P, Stallone G, Zaza G. mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis. Front Pharmacol 2021;12:710543. [PMID: 34497515 DOI: 10.3389/fphar.2021.710543] [Reference Citation Analysis]
4 Moris D, Kesseli SJ, Barbas AS. Kidney transplant recipients infected by COVID-19: Review of the initial published experience. Transpl Infect Dis 2020;22:e13426. [PMID: 32702150 DOI: 10.1111/tid.13426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM. COVID-19 and corticosteroids: a narrative review. Inflammopharmacology 2022. [PMID: 35562628 DOI: 10.1007/s10787-022-00987-z] [Reference Citation Analysis]
6 Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, Maiello C, Zampino R, Durante-Mangoni E. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Transpl Infect Dis 2021;:e13595. [PMID: 33641202 DOI: 10.1111/tid.13595] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Boregowda U, Perisetti A, Nanjappa A, Gajendran M, Kutti Sridharan G, Goyal H. Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020;7:586221. [PMID: 33123544 DOI: 10.3389/fmed.2020.586221] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
8 Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R. The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature. Medicina (Kaunas) 2021;57:435. [PMID: 33946462 DOI: 10.3390/medicina57050435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo JF, Simkins J, Morris MI, Abbo LA, Natori Y. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021;35:100588. [PMID: 33246166 DOI: 10.1016/j.trre.2020.100588] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]
10 Ferrari F, Visconti F, De Amici M, Guglielmi A, Colombo CN, Belliato M, Ronco C. Coronavirus disease 2019 in critically ill patients: can we re-program the immune system? A primer for Intensivists. Minerva Anestesiol 2020;86:1214-33. [PMID: 32755094 DOI: 10.23736/S0375-9393.20.14663-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I. A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts. J Clin Med. 2020;9. [PMID: 32947798 DOI: 10.3390/jcm9092986] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
12 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020;e13334. [PMID: 32449235 DOI: 10.1111/tid.13334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
14 Swanson KJ, Aziz F, Garg N, Mohamed M, Mandelbrot D, Djamali A, Parajuli S. Role of novel biomarkers in kidney transplantation. World J Transplant 2020; 10(9): 230-255 [PMID: 32995319 DOI: 10.5500/wjt.v10.i9.230] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]